Navigation Links
Anxiety help comes, eventually, via primary care
Date:11/7/2013

PROVIDENCE, R.I. [Brown University] A new study by Brown University psychiatry researchers found that seven in 10 primary care patients with anxiety disorders eventually received potentially adequate medication or psychotherapy, but for many it took years to happen and it was considerably less likely for minorities.

In the five-year study of 534 people published online Nov. 4 in the journal Depression and Anxiety, researchers found that 28 percent of them were receiving "potentially adequate" medication (19 percent) or psychotherapy (14 percent) or both when first recruited into the study from one of 15 primary care sites in four New England states. By year five of follow-up, 69 percent had received either or both appropriate medication (60 percent) or psychosocial treatment, such as cognitive behavioral therapy (36 percent).

"The good news here was that eventually, most patients got some good treatment," said study lead author Risa Weisberg, associate professor of psychiatry and human behavior at the Warren Alpert Medical School of Brown University. "The bad news is that pharmacotherapy wasn't sustained for long periods of time, that cognitive-behavioral therapy was rarely received even over the longer time period, and that ethno-racial minorities were less likely to get good care."

Most studies of anxiety treatment adequacy have only looked at one time point and have therefore found very low levels of care. But anxiety disorders are often chronic and primary care providers typically have an ongoing relationship with patients, Weisberg said. This study looked at a longer term.

Another key feature of the study was that it measured the provision of "potentially adequate" therapy. In the case of medication, that meant a drug had to have known efficacy and be taken at an adequate dose for enough time. For psychotherapy, the authors defined cognitive therapy or behavioral therapy as potentially adequate based on the method having empirical support and on meeting basic benchmarks such as identifying problematic patterns in thinking and recommending a course to change them or asking patients to conduct exposure exercises in which they attempt to engage in feared behaviors.

Although over the course of five years many patients eventually received care, some patients were less likely to receive it. Minorities, for example, were less than half as likely to receive "potentially adequate" treatment for anxiety either at the beginning of the five-year study period or by the end. People of any race or ethnicity with a college education, on the other hand, were almost twice as likely to receive care.

The patients were recruited through via the Primary Care Anxiety Project and were tracked through a follow-up period that ran from 2002 to 2007.

Weisberg said it is possible that rates of referral to potentially adequate care have categorically increased since then, but there was no evidence in the study data that the rates were systematically increasing during the study's five-year period.

Instead, she said, patients may take a while to eventually get potentially adequate care because primary care physicians often employ a strategy of "watchful waiting" to see if symptoms will improve. Weisberg and her co-authors noted in the study that patients with more severe anxiety symptoms were more likely to get potentially adequate care.

In a future work, Weisberg said, she hopes to study explicitly what triggers the start of anxiety therapy for primary care patients.


'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Related medicine news :

1. Depression, Anxiety Tied to Physical Disabilities in Seniors
2. Anxiety Might Help People Sniff Out Threats
3. Anxiety Linked to Smarts in Brain Study
4. One-third of adult Americans with arthritis battle anxiety or depression
5. Avatars may help children with social anxiety overcome fears
6. Anxiety, Depression May Raise Stroke Risk
7. beyondblue Launches Depression & Anxiety website and Info Line for Men
8. When anxiety wont go away
9. Math Anxiety Takes Bigger Toll on Girls: Study
10. Phobic Anxiety May Link to Premature Aging
11. Rutgers study: Anxiety disorders in poor moms likely to result from poverty, not mental illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... and clinical practice of radiosurgery, is recognizing five medical residents and students for ... stereotactic body radiotherapy (SBRT). The awards will be presented at the 2016 SRS/SBRT ...
(Date:5/24/2016)... ... 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered by ... Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold Member. ... is 6:30pm - 7:15pm followed by a small intro to the Oils that can ...
(Date:5/24/2016)... ... ... WaterAid launched the #perioddrama campaign to mark Menstrual Hygiene Day on May 28 and ... who do not have access to a toilet, even when they’re on their periods. , ... The (sometimes hilarious) results help shine a light on the awkwardness that women face while ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... trip to the Dominican Republic on September 21, 2016. Dr. Gerard, who holds ... serves with ChiroMission, a not-for-profit organization promoting health and wellness in Third World ...
(Date:5/24/2016)... , ... May 24, 2016 , ... The Dream Builders ... supplies and other necessities to Eunime Orphanage in Tijuana, Mexico on Saturday, May 21st. ... games at Peter Piper Pizza. , More than 15 volunteers traveled from Los ...
Breaking Medicine News(10 mins):
(Date:5/20/2016)... , May 20, 2016 The ... investors believe that the industry is not far from ... today ActiveWallSt.com featured the following four equities: Anacor Pharmaceuticals ... ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ... INFI ). Sign up for your free trading ...
(Date:5/19/2016)... , May 19,2016 Cellvizio ... Digestive Disease Week Meeting and 91 st ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... platform, today announced that its Cellvizio platform is ... on gastroenterology during the month of May. The ...
(Date:5/19/2016)... , The data will be presented in ... The conclusions of the study point to a ... 90% of the m presenting duration ... of the patients had clinical benefit.     ... study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed ...
Breaking Medicine Technology: